You know that managing diabetes takes work and time. If you are eating right, being physically active, and taking mealtime insulin but still not getting the results you want, maybe it is time to try something new. What is amylin? Amylin is a hormone that partners with insulin to help control blood sugar levels. Just as people with diabetes make little or no insulin, they also make little or no amylin. Without enough amylin and insulin, your blood sugar levels can go too high after meals. This is because:
SYMLIN is a medicine for people 18 years of age and older with type 2 or type 1 diabetes who take mealtime insulin.
The questions below can help you think about how your current diabetes treatment plan is working. Answer yes or no to each question.
Yes No
*SYMLIN is not indicated for weight loss or weight management.
SYMLIN is a medicine for people 18 years of age and older with type 2 or type 1 diabetes who take mealtime insulin. It partners with mealtime insulin to:
Find Out About SYMLIN
SYMLIN is a noninsulin diabetes medicine that helps people with diabetes control their blood sugar levels by replacing a hormone called amylin.How does SYMLIN help me?
*SYMLIN is not a weight-loss medicine. In a clinical trial, people with type 2 and type 1 diabetes lost an average of 6 pounds.
SYMLIN tells your brain that you are full sooner at meals. Although SYMLIN is not a weight-loss medicine, it may help you eat less. This may help you lose some weight.* Eating less food also means less sugar is going into your blood SYMLIN helps your stomach move food more slowly after meals, sending sugar into your blood more slowly SYMLIN helps your liver send less sugar into your blood
Learn more about SYMLIN® and mealtime insulin
Call 1-888-929-3873 and talk with a nurse to learn how SYMLIN teams up with your mealtime insulin for better blood sugar control.
As with all medicines, some people may notice side effects while taking SYMLIN. Not everyone has them, and some people may have different side effects from others. Knowing ahead of time what side effects may happen and working closely with your healthcare provider can help you manage them. Hear about the safety and side effects of SYMLIN from Tamara, a nurse with the SYMLIN Support Program. Read important information about SYMLIN, including information about the risk for severe low blood sugar, below.
SYMLIN Support Program The SYMLIN Support Program offers many benefits to people taking SYMLIN, including:
SYMLIN.com SYMLIN.com offers many tools and resources to help you manage your diabetes.
Interactive tools
SYMLIN Progress Tracker Record your blood sugar levels, the food you eat, and your physical activity to help you and your healthcare provider know how your diabetes treatment plan is going. If your healthcare provider prescribes SYMLIN, you can use this tool to track your progress with SYMLIN too!
Is SYMLIN Right for Me? checklist This checklist can help you know how well your diabetes treatment plan is working and help you talk with your healthcare provider about SYMLIN.
Downloadable resources
How SYMLIN Works brochure Learn how diabetes affects the body, how SYMLIN works, and how it can help you.
Helping You Get Started With SYMLIN brochure Learn how SYMLIN works with your mealtime insulin to control your diabetes, how to take SYMLIN, and what to expect during treatment.
Important information about SYMLIN SYMLIN is an injectable medicine used to control blood sugar after meals in adults with type 2 or type 1 diabetes who take mealtime insulin. SYMLIN works with mealtime insulin to smooth out the peaks in your blood glucose (sugar) levels to give you more stable levels after meals.
What is the most important information I should know about SYMLIN?
Nausea is the most common side effect with SYMLIN. Mild nausea is more likely during the first weeks after starting SYMLIN and usually does not last long. Tell your doctor if you have any side effects that bother you or that do not go away. Please see the SYMLIN Prescribing Information and Medication Guide, including information about the risk for severe low blood sugar.
01-10-10990-B. Updated on 05 Nov 2010. ©2010 Amylin Pharmaceuticals, Inc. All rights reserved. The SYMLIN mark, SymlinPen mark, and SymlinPen design mark are registered trademarks of Amylin Pharmaceuticals, Inc. SYMLIN Support Program is a service mark of Amylin Pharmaceuticals, Inc.
See what people are saying right now on Juvenation! The content below is not provided by Amylin Pharmaceuticals, Inc. The discussions are part of Juvenation.org